Compare ILMN & STZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ILMN | STZ |
|---|---|---|
| Founded | 1998 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5B | 24.6B |
| IPO Year | 2000 | 1987 |
| Metric | ILMN | STZ |
|---|---|---|
| Price | $135.47 | $160.43 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 17 |
| Target Price | $125.71 | ★ $168.65 |
| AVG Volume (30 Days) | 2.1M | ★ 3.0M |
| Earning Date | 02-05-2026 | 01-07-2026 |
| Dividend Yield | N/A | ★ 2.62% |
| EPS Growth | N/A | ★ 66.89 |
| EPS | 4.46 | ★ 6.27 |
| Revenue | $4,288,000,000.00 | ★ $9,383,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.79 | $0.34 |
| P/E Ratio | $31.64 | ★ $24.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $68.70 | $126.45 |
| 52 Week High | $155.53 | $196.91 |
| Indicator | ILMN | STZ |
|---|---|---|
| Relative Strength Index (RSI) | 40.68 | 60.82 |
| Support Level | $147.57 | $153.95 |
| Resistance Level | $153.48 | $160.45 |
| Average True Range (ATR) | 5.52 | 4.29 |
| MACD | -1.90 | -0.61 |
| Stochastic Oscillator | 3.90 | 60.60 |
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating 84% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands, effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 26% stake in no-moat Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.